Based on the Mani Inc stock forecast from 0 analysts, the average analyst target price for Mani Inc is not available over the next 12 months. Mani Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Mani Inc is Slightly Bearish, which is based on 6 positive signals and 10 negative signals. At the last closing, Mani Inc’s stock price was JPY 1,777.00. Mani Inc’s stock price has changed by -1.99% over the past week, +0.68% over the past month and -18.22% over the last year.
No recent analyst target price found for Mani Inc
No recent average analyst rating found for Mani Inc
Company Overview Mani Inc
Mani, Inc. engages in the manufacture and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, stainless wire needles, maniceps, septum stitch, and stent graft metal skeleton; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. The company was founded in 1956 and is headquartered in Utsunomiya, Japan. Read Less
Mani, Inc. engages in the manufacture and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, stainless wire needles, maniceps, septum stitch, and stent graft m...Read More
Frequently Asked Questions About Mani Inc (7730:TSE) Stock
Stock Target Advisor's fundamental analysis for Mani Inc's stock is Slightly Bearish.
7730:TSE stock's dividend yield is 2.54%.
Our analysis grades 7730:TSE stock's dividend yield at F. This means that 7730:TSE stock's dividend yield is above 46% of the stocks in the Medical Instruments & Supplies sector in the TSE exchange.
Based on this 7730:TSE may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 7730:TSE's stock to indicate what its average analyst target is.
7730:TSE stock's Price/Earning ratio is 28.23.
Our analysis grades 7730:TSE stock's Price / Earning ratio at F. This means that 7730:TSE stock's Price/Earning ratio is above 52% of the stocks in the Medical Instruments & Supplies sector in the TSE exchange.
Based on this 7730:TSE may be a overvalued for its sector.
The last closing price of 7730:TSE's stock was JPY 1,777.00.
The most recent market capitalization for 7730:TSE is JPY 177.58B.
Unfortunately we do not have enough analyst data on 7730:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Mani Inc's stock.
As per our most recent records Mani Inc has 0 Employees.
Mani Inc's registered address is 8-3 Kiyohara Industrial Park, Utsunomiya, Japan, 321-3231.
You can get more information about it from Mani Inc's website at https://www.mani.co.jp.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Mani Inc (7730:TSE) Stock
Stock Target Advisor's fundamental analysis for Mani Inc's stock is Slightly Bearish.
7730:TSE stock's dividend yield is 2.54%.
Our analysis grades 7730:TSE stock's dividend yield at F. This means that 7730:TSE stock's dividend yield is above 46% of the stocks in the Medical Instruments & Supplies sector in the TSE exchange.
Based on this 7730:TSE may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 7730:TSE's stock to indicate what its average analyst target is.
7730:TSE stock's Price/Earning ratio is 28.23.
Our analysis grades 7730:TSE stock's Price / Earning ratio at F. This means that 7730:TSE stock's Price/Earning ratio is above 52% of the stocks in the Medical Instruments & Supplies sector in the TSE exchange.
Based on this 7730:TSE may be a overvalued for its sector.
The last closing price of 7730:TSE's stock was JPY 1,777.00.
The most recent market capitalization for 7730:TSE is JPY 177.58B.
Unfortunately we do not have enough analyst data on 7730:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Mani Inc's stock.
As per our most recent records Mani Inc has 0 Employees.
Mani Inc's registered address is 8-3 Kiyohara Industrial Park, Utsunomiya, Japan, 321-3231.
You can get more information about it from Mani Inc's website at https://www.mani.co.jp.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 7730:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
